Organic Chemistry TRIZ Cases

Bifunctional compounds recruit MDM2 to E3 ligase for ubiquitination and degradation, improving target specificity in cancer therapy.

Blending lower- and higher-alkyl citrate esters balances plasticization efficiency with lower migration, volatile loss, and better heat resistance.

A mesogenic epoxy structure builds liquid crystal-like phonon pathways, raising cured thermal conductivity beyond filler-limited EMCs.

Multiple titanation with a titanium extractant removes low-activity sites, improving stereoselectivity and xylene solubles control with less donor use.

A specific salt and resin combination improves resist pattern formation by reducing line edge roughness without overly complicating composition design.

Purine-linked tricyclic scaffolds improve JAK1 selectivity, inhibition activity, and water solubility for autoimmune and cancer therapy.

Solvent-free amino methacrylate addition products improve UV LED surface cure under oxygen inhibition while reducing migration and yellowing.

Polycyclic non-fullerene acceptors improve solubility, synthesis, charge mobility, and oxidation stability in organic electronic devices.

Small-molecule αvβ6 inhibitors use tailored fluorinated linkers to balance target potency with in vitro permeability for oral treatment.

A soluble OLED compound combines multiple organic layer functions, enabling fully solution-processed fabrication with better efficiency and lifetime.

Modular enzyme pathways raise DPA in plant and microbial lipids to 7%–35% while keeping DHA below 2% for sustainable supply.

An isoindoline derivative acts as a growth inhibitor and rheology modifier to control pigment crystal size while preserving color strength and thermal stability.

Compounds with tailored substituent patterns improve ATM kinase inhibition potency and selectivity while supporting lower-toxicity cancer treatment.

Irreversible BTK inhibition mobilizes lymphoid cells into blood for biomarker profiling and better sequencing of therapy in refractory B-cell cancers.

A phenolic antioxidant and organic ester work together to slow peroxide decomposition, preserving shelf life, color, fragrance, and cleaning performance.

A fused-ring host material improves red or near-infrared OLED emission while maintaining heat resistance, low driving voltage, and longer lifetime.

Novel formula I compounds use N-linked bicyclic or spirocyclic rings to improve NLRP3 inhibition with better pharmacological properties.

A stable aficamten polymorph, Form Z1 combines high purity with controlled preparation to avoid form conversion during storage.

Calix[4]arenes bind and transport copper across membranes to disrupt copper homeostasis and kill chemoresistant cancer cells.

Nickel catalysts and methyl zinc reagents raise yield, suppress side-products, and enable scalable synthesis without palladium.

Bifunctional Degronimers link a target-binding ligand to a cereblon degron to improve selective protein degradation for cancer and blood disorders.

Specific HOMO and triplet energy matching across host materials helps organic EL layers sustain luminous efficiency and longer lifetime.

Biodegradable ester-bond ionizable lipids improve nucleic acid encapsulation and delivery while reducing inflammation and hepatotoxicity.

Structural changes in piperidine XPO1 inhibitors preserve cancer cell killing while reducing the systemic toxicities seen with Selinexor.

A citraconimide-epoxy resin blend lowers melt and room-temperature viscosity while preserving dielectric performance and heat resistance.

A luciferin-luciferase reagent emits light on contact with SARS-related coronaviruses, enabling rapid detection without complex PCR workflows.

Bio-derived anhydromevalonolactone replaces NMP and DCM in polymer dissolution and paint removal while lowering toxicity and fire risk.

Narrow-spectrum substituted tetracyclines target acne bacteria and inflammation while improving photostability and oxidative stability.

A one-pot reagent system deprotects and converts alpha halides to alkenyl or aldehyde products with high purity, fewer steps, and greener reagents.

Modular cereblon-binding degraders use linkers and targeting ligands to selectively recruit proteins for ubiquitin-proteasome degradation.

Dual NK-1/NK-3 antagonists lower LH and testosterone to treat sex-hormone diseases while avoiding flare, injection reactions, and other side effects.

A bimodal macropore-mesopore catalyst cuts diffusion resistance during ortho-alkylation, sustaining selectivity and conversion without cocatalysts.

Ionizable lipid nanoparticles protect nucleic acid drugs from degradation and improve cell membrane penetration for in vivo and in vitro delivery.

A KOtBu-based route forms key Ribociclib intermediates under mild conditions, avoiding heavy metals and silica gel purification.

A biaryl TNAP inhibitor raises pyrophosphate while improving solubility, permeability, and bioavailability to suppress ectopic calcification.

Asymmetric heterocyclic compounds boost triplet-triplet fusion in OLED emission layers, improving efficiency, luminance, driving voltage, and lifespan.

Novel RORγ inverse agonists address limited treatment efficacy by modulating inflammatory pathways and improving disease severity outcomes.

A carbonate-linked flavor compound prevents room-temperature volatilization, then releases flavor on heating to improve storage life and taste.

A Formula I compound uses tuned substituents to inhibit multiple KRAS mutants, supporting cancer treatment where conventional approaches fall short.

Aromatic amide derivatives target KIF18A to inhibit tumor cell proliferation, induce apoptosis, and support selective cancer therapy.

A fluorine-free onium salt resist composition improves acid dispersion to preserve low line width roughness during storage.

Specific methyl-substituted bisphenol compounds improve methanol color, thermal stability, and molecular weight control in polycarbonate resin production.

Selective FGFR2 compounds improve anti-tumor response while reducing FGFR1-linked hyperphosphatemia that limits pan-FGFR dosing.

Pre-mixing the palladium source, ligand, and base cuts Axitinib reaction time and lowers Pd residue for easier purification.

Selective ETA receptor antagonism with atrasentan lowers proteinuria, inflammation, and fibrosis while delaying ESRD in IgA nephropathy.

Isolated amino acids combined with nitrate compounds improve bioabsorption and rapid vasodilation while reducing dose requirements.

Isoxazole-substituted hydroxamic acids improve HDAC6 selectivity while preserving anticancer activity and sensitizing cancer cells to therapy.

Novel pyrrolidine compounds selectively modulate the glucocorticoid receptor to preserve anti-inflammatory activity while minimizing adverse effects.

Selective glycolysis inhibitors deplete ATP and reduce off-target kinase binding to address resistant AR-positive prostate cancer.

An intermediary emitting-auxiliary layer and tuned HOMO levels improve OLED charge balance, color purity, efficiency, and lifetime.

Infrared detection of fluorescent taggants identifies oil contamination sources, eliminating sampling delays.

Aromatic ring substituents on a fullerene core resolve electrical instability and abnormal short-wavelength absorption to boost external quantum efficiency.

Positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor improve cognitive symptoms while reducing L-DOPA-induced dyskinesia severity.

A specific organic compound lowers driving voltage in electroluminescent elements by optimizing energy levels across functional layers.

Halogen promotes cannabidiol cyclization to cannabinol while orthogonal chromatography removes impurities, resolving low yield and purity constraints.

Atropisomers target the Polo Box Domain of PLK1 and PLK4 kinases, improving brain penetration for treating glioblastoma.

Azaindenofluorenedione derivatives with dicyanomethylene groups serve as hole-injecting materials in organic electroluminescent devices.

Triglyceride composition with C14:1 and C16:1 fatty acids reduces viscosity while maintaining high flash point.

A crystalline PDE5 inhibitor form distributes preferentially to vascular tissue.

Serial reactors enable continuous anhydrosugar alcohol production, eliminating batch inefficiencies and boosting industrial capacity.

A three-step purification process for cefotiam hydrochloride using acidic salt treatment and solvent extraction to achieve high purity.

Fluorinated unsaturated cyclic carbonate improves lithium ion battery efficiency and capacity recovery while reducing gas generation at high temperatures.

Nitroxide compounds scavenge oxygen radicals to reduce oxidative stress in preeclampsia.

Heterocyclic benzimidazolo compounds with triazine groups enable balanced electron transport in organic light emitting diodes.

Chiral Cu(II) complexes mediate anti-selective nitro-aldol reactions, establishing correct steric configurations in single-step synthesis.

Derivatizing polyethylene glycol metabolites with pentafluorobenzoyl chloride overcomes low sensitivity and poor reproducibility in standard assays.

Synthesizing linear mono- and dialkyl ethers of furan-2,5-dimethanol in polar aprotic solvents reduces production costs for bio-based surfactants.

Liquid-liquid amine hydrofluoride reactions replace slow solid-liquid processes to accelerate reaction rates and eliminate solid removal steps.

Segmented synthesis of cycloalkylcarboxamido-pyridine benzoic acids overcomes manufacturing economy constraints while maintaining production efficiency.

Diindenopyrazine-based compounds improve blue light color purity and luminescent efficiency by lowering driving voltage through enhanced electron-hole mobility.

A triacylglycerol dimer disrupts saturated fatty acid methyl ester packing to delay nucleation and crystal growth in biodiesel fuels.

Bisoxime antidotes catalyze hydrolysis of organophosphate-inhibited acetylcholinesterase in central nervous system tissues.

Beta-3 adrenergic receptor antagonists enhance cardiac contractility and improve hemodynamic status in failing hearts.

Controlling 8-to-10 carbon aliphatic impurities below 500 mg/kg preserves zeolitic catalyst selectivity and conversion rates.

Formula I sterically hindered amine compounds stabilize polymers against light, heat, and oxidation without adding stickiness or resinification.

Novel benzenesulfonamides activate GPR40 and GPR120 receptors to stimulate insulin secretion.

Modifying chemical structures of heterocyclic compounds reduces side effects while improving treatment efficacy for cancers.

Bio-based oxygen scavenging polymers reduce oxygen transmission in PET, preserving freshness without haze.

An organic solvent extracts acid catalysts from aqueous hydrolysis mixtures, eliminating complex acid recovery systems while maintaining high sugar yields.

Precise zinc parameter control in ZnTiMWW zeolites resolves the selectivity-efficiency trade-off during propylene oxide production.

Fused pyrimidine pyridinone compounds selectively inhibit JAK3 to treat inflammatory diseases while minimizing systemic immunosuppression.

Novel non-lipid compounds selectively inhibit autotaxin enzyme activity through distinct molecular structures.

Reaction products of amino acids and epoxies act as leveling agents in copper electroplating baths to deposit uniform metal layers.

Compounds targeting TLR2 heterodimerization suppress pathological inflammation while preserving non-pathological immune responses.

A linear upconversion fluorophore emits shorter-wavelength light upon excitation, enabling precise biomaterial sensing with standard LEDs.

Dithiocarbamic acid depressants selectively adsorb onto copper and iron sulfide surfaces to prevent bubble attachment during froth flotation.

A two-stage vacuum drying process removes organic solvents and water from halohydantoin compounds at controlled temperatures.

Replacing Raney Nickel desulfurization with a sulfur-free pathway eliminates heavy metal waste while increasing yields of pyrrolopyrimidin-4-ols.

Cyclic sulfonic acid esters form protective films on electrodes to maintain low-temperature output after high-temperature storage.

Administering ferroptosis inhibitors limits ferroptotic cell death, extending lifespan despite variable results from existing iron chelation methods.

Chlorinating and reducing imidazole intermediates to produce losartan derivatives, resolving low yields from harsh reaction conditions.

Segmenting retardation properties across orthogonal liquid crystal layers resolves the trade-off between device weight and broad spectral uniformity.

A specific organic electroluminescent compound serves as a host material to improve driving voltage and luminous efficiency.

A novel organic compound serves as a multi-functional material in OLED layers to improve light efficiency.

N-substituted imidazole carboxylate compounds deliver rapid anesthetic onset and quick recovery through structural modifications at the imidazole ring positions.

Internal olefin sulfonate composition prevents phase separation during transport by maintaining a hydroxy to alkene sulfonate ratio of at least 3.25.